jRCT2032210323进行中（未招募）不适用
Prospective, multi-center, randomized, double-blind sham-controlled trial of the urinary dysfunction treatment device O-NES in patients with refractory overactive bladder with urinary incontinence (pivotal trial)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 180
- 主要终点
- The change in the mean frequency of urinary incontinence episodes per day
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •They are aged 20 years or older at the time they give their informed consent.
- •They have been treated with anticholinergic drugs and beta3 receptor agonists in the past, but the symptoms of overactive bladder are persisting or they cannot use therapeutic drugs of overactive bladder due to certain reasons such as contraindications.
- •They have 2 points or higher of urinary urgency score (question 3) and 2 points or higher of urgency urinary incontinence score (question 4) in OABSS.
- •Their mean urinary incontinence with urinary urgency per day is 1 time or more and their mean urinary frequency per day is 8 times or more.
- •They have will and able to accurately record the urinary diary and complete the questionnaire throughout the trial period.
排除标准
- •They wear any implantable electronic device (e.g. pacemaker).
- •They have been treated with neuromodulation therapy (electrical stimulation, magnetic stimulation, etc.) for overactive bladder.
- •They have a history of treatment with botulinum toxin for the bladder.
- •They started treatment with the following drugs within 4 weeks prior to informed consent (including new, resumption, or drug switching): Alternatively, the dosage and administration were changed or discontinued.
- •Anticholinergic drugs or beta3 receptor agonists used for the purpose of improving the symptoms of overactive bladder
- •alpha1-blockers or PDE-5 inhibitors used to improve the symptoms of benign prostatic hyperplasia.
- •They were diagnosed with stress urinary incontinence as the main symptom of urinary incontinence.
- •They have urinary dysfunction, nocturnal enuresis, inflammatory diseases of the lower urinary tract (interstitial cystitis, bacterial cystitis, prostatitis, etc.), urinary stone (urethral stone, bladder stone, ureteral stone).
- •They have a history of surgery to remove a malignant tumor in the pelvis.
- •They have treatment-requiring pelvic organ prolapse or have a history of pelvic organ prolapse surgery within 6 months before informed consent.
- •They have residual urine volume of exceeding 100 mL or have mechanical (organic) obstruction in the lower urinary tract or have clinically problematic lower urinary tract obstruction disease (such as benign prostatic hyperplasia).
- •They are carrying out indwelling catheterization or intermittent self-catheterization.
- •They have symptoms of overactive bladder of neurological cause.
结局指标
主要结局
The change in the mean frequency of urinary incontinence episodes per day
时间窗: fourth week
The change from the baseline in the treatment fourth week
次要结局
- The rate of change in the mean frequency of urinary incontinence episodes per day from the baseline
- The mean daily urinary urgency and its change from the baseline
- The rate of change in the mean daily urinary urgency from the baseline
- The change in the total Overactive Bladder Symptom Score (OABSS) from the baseline
- The mean daily urinary frequency and its change from the baseline
- The rate of change in the mean daily urinary frequency from the baseline
- The mean voided volume per micturition and its change from baseline
- The maximum voided volume per micturition and its change from the baseline
研究者
相似试验
已完成
Unknown
ovel Urine Test to Determine Abnormal Cell Metabolism in adults 40 - 80 years oldconfirmed malignancyCancer - Any cancerACTRN12624001029583ATH (Australia) Pty Ltd100
已完成
不适用
A double-blind randomised controlled trial of the heat-inactivated Pediococcus acidilactici K15 in preterm infant to prevent viral respiratory tract infection after NICU discharge.Prevention of viral respiratory tract infectionJPRN-UMIN000033758Chiba University41
已完成
不适用
A double-blind randomised controlled trial of the efficacy of low level laser therapy on wound healing following nail surgerySkin and connective tissue diseasesSkin and Connective Tissue DiseasesISRCTN63833651HS R&D Regional Programme Register - Department of Health (UK)
已完成
2 期
A double-blind, randomized controlled trial of the effects of continuous intake of 1-kestose on defecation habits in children in kindergarteconstipationJPRN-UMIN000044252Center for Preventive Medical Sciences, Chiba University23
进行中（未招募）
1 期
Effectiveness of Botulinum toxin Type A injection (Dysport®) to restore quadriceps muscle balance and improve chronic knee paiChronic anterior knee pain?Musculoskeletal - Other muscular and skeletal disordersACTRN12605000775617Dr BJ Singer, School of Surgery and Pathology, The University of Western AustraliaMedical Research Foundation Building, Level 2, Rear 50 Murray Street, Perth, WA 600025